Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway
Healthspan offers personalized weight-loss prescriptions, including GLP-1 medications such as semaglutide, tailored to your biology, medical history, and goals
Peel a grapefruit and add it to green salads or breakfast
mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib
About ATTAIN-MAINTAIN trial and ATTAIN clinical trial program ATTAIN-MAINTAIN (NCT06584916) was a 52-week, Phase 3, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of once-daily orforglipron versus placebo for maintenance of body weight reduction in adults with obesity or overweight with weight-related comorbidities who previously completed the SURMOUNT-5 head-to-head trial
US$ 25.21
US$ 22.85
US$ 22.53
US$ 28.57
US$ 27.64
US$ 27.18
